Kevin Bitterman sold $4.4M of IRON
director at Disc Medicine, Inc.. 54,496 shares at an average of $80.15, traded Sep 1, 2026, filed Sep 3, 2026.
Score components
- +15RoleDirector
- +25Trade size$4.4M at market
- +5Share of holdings soldSold 16% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001591747-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -70 | $79.95 | $5,597 | 349,140 | 39 d ago |
| Sep 1, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -58 | $79.95 | $4,637 | 337,427 | 39 d ago |
| Sep 1, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -1 | $79.95 | $80 | 14,012 | 39 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -26,542 | $80.17 | $2.1M | 322,598 | 39 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -22,090 | $80.17 | $1.8M | 315,337 | 39 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -511 | $80.17 | $41k | 13,501 | 39 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -10 | $80.98 | $810 | 322,588 | 39 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -9 | $80.98 | $729 | 315,328 | 39 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -2 | $80.98 | $162 | 13,499 | 39 d ago |
| Sep 3, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -2,810 | $79.98 | $225k | 319,778 | 39 d ago |
| Sep 3, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -2,339 | $79.98 | $187k | 312,989 | 39 d ago |
| Sep 3, 2026 | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -54 | $79.98 | $4,319 | 13,445 | 39 d ago |
Related signals
Other insiders at Disc Medicine, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | IRONsell Disc Medicine, Inc. | Kevin Bitterman director | $1.9M 27,136 shares | -100% | |
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $135k 1,689 shares | -1% | |
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $140k 2,287 shares | -0% | |
| 20Weak | Disc Medicine, Inc. | Kevin Bitterman director | $2.0M 32,174 shares | -5% | |
| 0Weak | Disc Medicine, Inc. | Kevin Bitterman director | $24k 395 shares | -0% | |
| 13Weak | Disc Medicine, Inc. | Kevin Bitterman director | $518k 8,492 shares | -1% | |
| 40Moderate | IRONsell Disc Medicine, Inc. | Kevin Bitterman director | $2.6M 42,870 shares | -6% | |
| 21Weak | IRONsell Disc Medicine, Inc. | Kevin Bitterman director | $41k 664 shares | -0% | |
| 20Weak | Disc Medicine, Inc. | Jean M. Franchi Chief Financial Officer | $105k 2,000 shares | -3% | |
| 14Weak | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $150k 2,996 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.